Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 18, 2021

SELL
$78.5 - $126.48 $5.2 Million - $8.39 Million
-66,303 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$55.93 - $82.78 $478,313 - $707,934
-8,552 Reduced 11.42%
66,303 $5.25 Million
Q3 2020

Nov 17, 2020

SELL
$45.65 - $61.81 $2.24 Million - $3.03 Million
-49,074 Reduced 39.6%
74,855 $4.23 Million
Q2 2020

Aug 13, 2020

SELL
$29.15 - $61.54 $527,615 - $1.11 Million
-18,100 Reduced 12.74%
123,929 $7.63 Million
Q1 2020

May 18, 2020

BUY
$25.01 - $42.4 $388,280 - $658,260
15,525 Added 12.27%
142,029 $4.58 Million
Q4 2019

Feb 14, 2020

BUY
$24.55 - $38.13 $1.44 Million - $2.24 Million
58,722 Added 86.63%
126,504 $4.45 Million
Q3 2019

Nov 14, 2019

BUY
$25.78 - $34.8 $1.28 Million - $1.72 Million
49,503 Added 270.82%
67,782 $1.75 Million
Q1 2019

May 15, 2019

SELL
$27.81 - $40.78 $1.08 Million - $1.58 Million
-38,737 Reduced 67.94%
18,279 $625,000
Q4 2018

Feb 14, 2019

SELL
$28.91 - $50.0 $1.24 Million - $2.15 Million
-42,975 Reduced 42.98%
57,016 $1.82 Million
Q3 2018

Nov 14, 2018

SELL
$30.85 - $50.65 $2.59 Million - $4.25 Million
-83,850 Reduced 45.61%
99,991 $4.8 Million
Q2 2018

Aug 14, 2018

SELL
$13.95 - $32.65 $123,108 - $288,136
-8,825 Reduced 4.58%
183,841 $5.7 Million
Q1 2018

May 15, 2018

SELL
$14.35 - $16.5 $1.94 Million - $2.23 Million
-135,100 Reduced 41.22%
192,666 $2.85 Million
Q4 2017

Feb 22, 2018

SELL
$12.45 - $17.4 $1.35 Million - $1.88 Million
-108,269 Reduced 24.83%
327,766 $5.08 Million
Q3 2017

Nov 14, 2017

BUY
$10.25 - $12.8 $4.47 Million - $5.58 Million
436,035
436,035 $5.43 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.72B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Grandeur Peak Global Advisors, LLC Portfolio

Follow Grandeur Peak Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandeur Peak Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandeur Peak Global Advisors, LLC with notifications on news.